pharmaphorum June 9, 2023
Phil Taylor

One of the most compelling things about artificial intelligence chat technologies like ChatGPT and AIChat is their ability to generate human-like responses – but that may not be the best approach when trying to apply them to complex applications like biomedical research.

To make the technology more relevant for researchers, companies have started to develop new platforms with a deeper understanding of the language and processes used in life sciences – notably, Microsoft with its recently-unveiled BioGPT – which aim to be more useful to researchers.

At BIO this week, Boston-based tech company Epistemic AI officially launched its own entry into the embryonic category, EpistemicGPT, with the promise to allow researchers to “interact with highly complex data in a way...

Today's Sponsors

Upfront Healthcare

Today's Sponsor


Topics: Biotechnology, Conferences / Podcast, Pharma / Biotech, Trends
Beyond CD-ROMs
Unraveling the complex enigma of obesity [PODCAST]
Journalists Track Opioid Settlement Cash and New Fees for Emailing Your Doctor
AI Revolution: Disruption, Alignment, and Opportunity
Innovative Solutions in Medication Packaging Can Improve Adherence

Share This Article